Latest Innovation News

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

Viridis Mining and Minerals has been selected for a major Brazilian government funding package to accelerate its Colossus rare earth elements project, marking a pivotal step in diversifying global critical mineral supply chains.

AdAlta Limited has successfully placed the remaining shortfall in its renounceable rights issue, raising a total of $1.3 million to advance its cellular immunotherapy pipeline. The company also addressed an administrative breach involving director share allocations, ensuring compliance with ASX rules.

Meteoric Resources has secured inclusion in Brazil’s major Strategic Minerals funding program, aiming to advance its Caldeira Rare Earths Project and downstream magnet production.

Ionic Rare Earths’ Brazilian joint venture, Viridion, has been selected for significant government funding to accelerate rare earth refining and magnet recycling, marking a major step in Brazil’s strategic push for a secure, sustainable supply chain.

ASX Limited has finalised the sale of its investment in Digital Asset Holdings for $57 million, securing a substantial pre-tax gain that will bolster its FY25 financial results.

Syntara Limited is set to reveal fresh interim results from its Phase 2 trial of SNT-5505, targeting myelofibrosis, during an investor webinar ahead of a major European hematology conference.

Challenger Limited has welcomed APRA’s consultation on new capital settings for annuity products, highlighting the potential for regulatory reforms to boost innovation and growth in Australia’s retirement income sector.

PointsBet Holdings has secured Foreign Investment Review Board approval for MIXI Australia's proposed full acquisition, marking a key regulatory milestone in the takeover process.

HITIQ has partnered exclusively with Shock Doctor to launch the PROTEQT instrumented mouthguard, aiming to transform concussion management worldwide. The company also initiates a $2.92 million rights issue to fuel this ambitious rollout.

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.